arrow
G

Girolama Alessandra Marfia

tor vergata university and tor vergata university hospital
H指数:43
被引数:8,049

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study)

评估接受不同治疗方案序列治疗的视神经脊髓炎患者队列中长期严重不良事件风险的概况:意大利视神经脊髓炎及相关疾病登记研究(I-MS&RD)(ProSA研究)结果

2026-07-040
PRE
Real-world experience with cladribine tablets in people with multiple sclerosis: effectiveness data from a multicenter Italian study

真实世界中多发性硬化患者使用克拉屈滨片的经验:一项多中心意大利研究的有效性数据

2025-12-260
OA
Maternal and fetal outcomes in an Italian multicentric cohort of women with multiple sclerosis exposed to dimethyl fumarate during pregnancy

怀孕期间暴露于富马酸二甲酯的多发性硬化症妇女的意大利多中心队列的母婴结局

2024-09-120
PRE
Ocrelizumab in MS patients with persistence of disease activity after alemtuzumab: A multi-center Italian study

Ocrelizumab在阿仑单抗治疗后疾病活动持续存在的MS患者中: 一项多中心意大利研究

2024-08-140
PRE
Predicted Expenditure for Prescription Drugs for Multiple Sclerosis in the Italian Market Between 2023 and 2028: Results of the Oracle Project
2024-08-020
OAAI
A comparison of natalizumab and ocrelizumab on disease progression in multiple sclerosis

那他珠单抗和ocrelizumab对多发性硬化疾病进展的比较

2024-07-053
OA
Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study

那他珠单抗治疗继发性进行性多发性硬化的长期疗效: 一项倾向匹配研究

2024-07-011
OAAI
Treatment modifiers across different regimens of natalizumab treatment in MS: An Italian real-world experience

在MS中使用那他珠单抗治疗的不同方案中的治疗调节剂: 意大利的真实世界经验

2024-04-011
OAAI
CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barre Syndrome
2023-06-0618
OA
Sars-CoV2 infection in pregnant women with multiple sclerosis

多发性硬化症孕妇的Sars-CoV2感染

2023-05-261
OA
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy
2023-04-045
PRE
Exposure to natalizumab throughout pregnancy: effectiveness and safety in an Italian cohort of women with multiple sclerosis

整个怀孕期间暴露于那他珠单抗: 在意大利多发性硬化症女性队列中的有效性和安全性

2022-09-3015
PRE
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy
2022-09-0816
OA
Predictors of Cladribine Effectiveness and Safety in Multiple Sclerosis: A Real-World, Multicenter, 2-Year Follow-Up Study

克拉屈滨在多发性硬化症中有效性和安全性的预测因素: 一项真实世界,多中心,2年随访研究

2022-06-0229
OAAI
Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values
2022-06-0111
OAAI